SCIENTIFIC PROGRAMME  OF THE 2ND ICCD, KOSICE, 2002

13,00-13,25
1. HOMOCYSTEINE IN COMPARISON TO PRIMARY RISK FACTORS FOR CAD: ARE INTERGENDER DIFFERENCES CLUE TO LOWER FEMALE MORTALITY?
G.J.Fodor,  J. Lietava*, M. Kotrec*, V. Krpčiar*, M. Čaprnda*, D. Križanová*, J. Taliga*, A. Dukát*, P. Blažíček**, University of Ottawa Heart Institute, Ottawa, Ontario, Canada, * 2^nd  Department of Internal Medicine, Comenius University, Bratislava, Slovakia, ** Department of Clinical Laboratories Hospital of Ministry of Defence, Bratislava, Slovakia

13,25-13,50
2. NIACIN-INDUCED HYPER-HOMOCYSTEINEMIA, AN INDEPENDENT RISK FACTOR FOR ARTERIAL OCCLUSIVE DISEASE
Tapan K. Basu, Department of Agricultural, Food & Nutritional Science University of Alberta, Edmonton,
Alberta, Canada

13,50-14,10
3. IS MILD HYPERHOMOCYSTEINEMIA A PART OF METABOLIC SYNDROME OF INSULIN RESISTANCE ?
Hana Rosolova, Otto Mayer Jr., Jaroslav Simon, Jakub Cech, Center of Preventive Medicine, Pilsen, Czech republic

14,10-14,30
4. INFLUENCE OF IMPAIRED NUTRITION ON HOMOCYSTEINE LEVEL IN PATIENTS WITH ISCHEMIC HEART DISEASE.
Ján Lietava,  M. Čaprnda, M. Rakovan, K. Jarošová, A. Dukát, P. Blažíček,  G.J. Fodor*,  2^nd  Department of Internal Medicine, Comenius University, Bratislava, Slovakia,  * University of Ottawa Heart Institute, Ottawa, Canada
 
 

13,00–14,30  HALL B CARDIOVASCULAR PHYSIOLOGY AND PATHOPHYSIOLOGY  Chairpersons: Naranjan S. Dhalla , Dennis B. McNamara

13,00-13,20
1. ANTIOXIDANT DEFICIT AND INCREASED OXIDATIVE STRESS DURING HEART FAILURE  SUBSEQUENT TO CORONARY OCCLUSION
Pawan K.Singal, Michael F. Hill, Neelam Khaper, Institute of Cardiovascular Sciences, Dept. of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada

13,20-13,40
2. THE WOUND HEALING  RESPONSE OF THE VASCULAR WALL IN A MODEL OF TYPE 1 DIABETES
Dennis B. McNamara, Department of Pharmacology  Tulane University Medical Center New Orleans, USA

13,40-14,00
3. SUBCELLULAR REMODELING IN HEART FAILURE
Naranjan S. Dhalla, Institute of Cardiovascular Sciences St.Boniface Gen. Hospital Research Centre The University of Manitoba, Winnipeg, Canada

14,00-14,15
4. EXOGENOUS COENZYME Q10 STIMULATES ITS LEVEL AND MITOCHONDRIAL ENERGY PRODUCTION IN AGEING
Anna Gvozdjakova, J. Kucharská, Z. Sumbalová, F. Mikla,*, J. Murín*,  Faculty of Medicine, Pharmacobioch. Lab., Bratislava, Slovakia, * Department of Internal Medicine of Medical Faculty, Bratislava, Slovakia

14,15-14,30
5. SYMPATHETIC ACTIVATION AND PARASYMPATHETIC WITHDRAWAL IN PATIENTS WITH HEART FAILURE AND SLEEP APNEA
Ruzena Tkacova, Clinic  of Pulmonary Medicine, Medical Faculty, PJ Safarik University, Kosice, Slovakia

ANGIOTENSIN RECEPTOR BLOCKERS: NEW THERAPEUTIC APPROACH
Andrej Dukát, 2^nd  Department of Internal Medicine, Comenius University, Bratislava, Slovakia

AT₁-RECEPTOR BLOCKADE: HYPERTENSION MANAGEMENT
Jozef Gonsorcik, 4^th Dept. of Internal Medicine University Hosp. L.Pasteur, Kosice, Slovakia

FUTURE FOR AT₁-RECEPTOR BLOCKERS
Daniel Pella,  2^nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia
 
 

15,00 - 16,30  Hall B GLAXOSMITHKLINE SYMPOSIUM Lacidipine - Dual Action Against Atherosclerotic Process

STATE OF THE ART - CALCIUM CHANNEL ANTAGONISTS AFTER LANDMARK CLINICAL TRIALS AND METAANALYSES
Robert Hatala, Department of Arrhythmias Slovak Cardiovascular Institute, Bratislava, Slovakia

ANTIATHEROGENIC PROPERTIES OF LACIDIPINE
Miroslav Slanina, Cardiology Department, Presov, Slovakia

ELSA - EUROPEAN LACIDIPINE STUDY ON ATHEROSCLEROSIS - PRINCIPAL RESULTS
Juraj Vančík, Cardiology Department, US Steel Hospital, Kosice, Slovakia

THE ROLE OF STATINS IN THE TREATMENT OF PATIENTS WITH DIABETES AND INSULIN RESISTANCE.
Ivan Tkáč, Department of Internal Medicine IV, Košice, Slovakia

STATINS IN THE TREATMENT OF CHD, FORCUSED ON ATORVASTATIN
Richard Češka, Center of Preventive Cardiology  III^rd Internal Clinic 1.School of Medicine Charles University, Prague, Czech Republic

ATORVASTATIN CLINICAL PROGRAM
Slavomíra Filipová, Slovak Institute of Cardiovascular Diseases, Dept. Cardiology, Bratislava, Slovakia

PLAQUE STABILITY - ROLE OF STATINS
Daniel Pella,  2^nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia
 
 

16,45 - 18,15  Hall B BOEHRINGER INGELHEIM SYMPOSIUM Telmisartan for Your Good Morning - Sustained 24-Hour Blood Pressure Control

TELMISARTAN - NOVEL APPROACH IN HYPERTENSION THERAPY
Rafael Rybár, 2^nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia

TELMISARTAN AND AMLODIPINE - COMPARISON OF EFFICACY AND SAFETY
Juraj Vančík, Cardiology Department, US Steel Hospital, Kosice, Slovakia

CLINICAL TRIAL : ON TARGET
Oktavián Kuchárik, Boehringer Ingelheim, Bratislava
 

MANAGEMENT OF THE RISK FACTORS OF ATHEROSCLEROSIS
Andrej Dukát, 2^nd  Department of Internal Medicine, Comenius University, Bratislava, Slovakia

AMLODIPINE IN THE TREATMENT OF STABLE ANGINA PECTORIS
Martin Studenčan, Cardiology Center,Kosice, Slovakia

ANTIATHEROGENIC EFFECT OF AMLODIPINE
Rudolf Uhliar, Hospital Ministry of Interior, Bratislava, Slovakia

 IMPORTANCE OF PREVENT STUDY FOR CLINICAL PRACTICE
 Andrej Zachar, 3^rd Medicla Clinic Komensky University, Derer´s Hospital, Bratislava, Slovakia
 
 

08,00 - 09,30  Hall B LABORATOIRES FOURNIER SYMPOSIUM HDL Cholesterol - New Therapeutic target in prevention and therapy of  CAD

HDL CHOLESTEROL AND CORONARY HEART DISEASE: IMPLICATIONS FROM THE CLINICAL TRIALS
Ivan Tkáč, Department of Internal Medicine IV, Košice, Slovakia

DAIS: EVIDENCE BASED MEDICINE
Vladimír Uličiansky, Department of Internal Medicine University Hospital, Kosice, Slovakia

TREATMENT TO THE TARGET LEVELS OF HDL-CHOLESTEROL
Daniel Pella,  2^nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia

10,00-10,30
1. NEW CONCEPTS IN ATHEROSCLEROSIS, CORONARY AND CEREBRO-VASCULAR DISEASE
Chris J. Packard, Glasgow Royal Infirmary,  Glasgow, United Kingdom

10,30-11,00
2. DO WE NEED MORE RISK FACTORS FOR THE PREDICTION OF ATHEROSCLEROSIS?
Michael Schachter, Department of Clinical Pharmacology  Imperial College St Mary's Hospital London,  United Kingdom

11,00-11,30
3. CHALLENGES IN THE PREVENTION OF ATHEROSCLEROSIS IN THE ASIAN PACIFIC REGION
Edward D. Janus,  Wimmera Health Care Group,  Horsham,Victoria, Australia
 
 

10,00–11,30  Hall B CURRENT TRENDS IN MANAGEMENT OF ARRHYTHMIAS AND SYNCOPE Chairpersons: M. Brignole,  J. Gonsorčík

10,00-10,30
1. ELECTROCARDIOGRAPHIC DOCUMENTATION OF SPONTANEOUS SYNCOPE. THE RESULTS OF THE ISSUE STUDY.
Michele Brignole, Department of Cardiology Ospedali del Tigullio, Lavagna, Italy

10,30-11,00
2. VASOVAGAL SYNCOPE - THERAPY AND FOLLOW- UP.
Peter  Mitro, Rafael Rybár, Daniel Pella, Gabriel Valočik, Dept. of Internal Medicine II Medical Faculty, Kosice, Slovakia

11,00-11,20
3. CLINICAL MANAGEMENT OF PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA  / ARVD/
Peter Lukac, Peter Margitfalvi, Lubos Urban, Tibor Malacky, Robert Hatala, Department of Arrhythmias Slovak Cardiovascular Institute Bratislava, Slovakia

11,40-12,10
1. PHARMACOLOGICAL PROTECTION OF THE ARTERIAL WALL: EFFECTS ON MYOCARDIAL INFARCTION AND STROKE
Rodolfo Paoletti, Department of Pharmacological Sciences, University of Milan,  Milan, Italy

12,10-12,40
2. STATINS FOR EVERYONE ?
Michael Schachter, Department of Clinical Pharmacology  Imperial College, St Mary's Hospital, London, United Kingdom

12,40-13,05
3. PPAR ALPHA ACTIVATORS IN CARDIOVASCULAR DISEASE
Patrick Duriez, Institut Pasteur de Lille - Département d'Athérosclérose, Lille, France

13,05-13,30
4. STATINS,  FIBRATES OR THE COMBINATION: WHICH IS BEST TO PREVENT ATHEROSCLEROSIS ?
Brian Tomlinson,  Division of Clinical Pharmacology Department of Medicine and Therapeutics Prince of Wales Hospital, Shatin, HKSAR, HongKong, China
 
 

11,40 –13,30 Hall B CLINICAL STUDIES AND  PROGRAMS Chairpersons: Ch. Holubarsch, J.Vančík

11,40-12,05
1. SURVIVAL AND PROGNOSIS: INVESTIGATION  OF CRATAEGUS EXTRACT WS 1442 IN CONGESTIVE HEART FAILURE ( SPICE ). RATIONALE AND DESIGN
 Christian J.F. Holubarsch, University of Freiburg and Heart and Circulation Clinics,Waldkirch b. Freiburg/Br., Germany

12,05-12,30
2. HYPERTENSION AND CARDIOVASCULAR RISK FACTOR CONTROL PROGRAM IN ISRAEL
 J. Reuven Viskoper, D. Dicker, D. Gavish, C. Yosefi- in mae of IBPC collaborators,   Department of Medicine B and the WHO Collaborative Center for Prevention of CV diseases Barzilai Medical Center Ben Gurion University of the Negev Ashkelon,  Bear-Sheba, Israel

12,30-12,50
3. TRIMETAZIDINE IN GERIATRIC PATIENT WITH STABLE ANGINA PECTORIS : THE TIGER STUDY
Viliam Bada, F. Kolbel*, 3^rd Medical Clinic  Komensky University, Dérer´s Hospital Bratislava, Slovakia
* Internal Clinic of Charles University, Hospital, Motol Prague, Czech Republic

12,50-13,10
4. DIAGNOSIS AND TREATMENT OF HEART FAILURE IN THE PRAXIS OF GP´S IN THE CZECH AND SLOVAK REPUBLICS IN 1999-2000. RESULTS OF THE EUROPEAN IMPROVEMENT OF HF PROGRAM.
Jiří Widimský, Department of Cardiology IKEM, Prague, Czech republic

13,10-13,30
5. SYSTOLIC HYPERTENSION IN THE ELDERLY: RESULTS OF THE SYST-EUR STUDY
Jan Filipovsky, II. Internal clinic LF UK and FN Pilsen, Czech  republic

15,00-15,25
1. SELECTIVE ALDOSTERON RECEPTOR ANTAGONISTS: BEYOND RENIN ANGIOTENSIN INHIBITION
Hans Armin Dieterich, Parexel GmbH Klinikum Westend, Berlin, Germany

15,25-15,50
2. PREVENTION OF SUDDEN CARDIAC DEATH – IS THERE STILL A PLACE FOR PHARMACOTHERAPY ?
Robert Hatala, Department of Arrhythmias Slovak Cardiovascular Institute, Bratislava, Slovakia

15,50-16,10
3. PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR LIGANDS AS THERAPEUTICS FOR VASCULAR DISEASE.
Peter Zahradka, Institute of Cardiovascular Sciences St. Boniface Research Centre Winnipeg, Canada

16,10-16,30
4. ANGIOTENSIN II ANTAGONISTS IN THE THERAPY OF ATHEROSCLEROSIS AND HYPERTENSION
Daniel Pella,  2^nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia
 
 

15,00–16,30 Hall B ROLE OF DIET IN  PREVENTION OF CARDIOVASCULAR DISEASES  Chairpersons: E.M. Berry, J.Vančík

15,00-15,25
1. THE EFFECT OF AN INDO-MEDITERRANIAN  DIET ON THE PROGRESSION OF CORONARY ARTERY DISEASE IN HIGH RISK PATIENTS: THE INDO-MEDITERRANEAN DIET HEART STUDY.
Elliot M. Berry, R. B. Singh*, G. Dubnov, M. A. Niaz, Si Ghosh, R. Singh*, S. S. Rastogi, O. Manor, D. Pella**,Dept of Human Nutrition & Metabolism Hebrew University-Hadassah Medical School, Jerusalem, Israel , * Research centre, Moradabad, India, ** Safaric University, Kosice, Slovakia

15,25-15,50
2. DIETARY POLYPHENOLS AND THE PREVENTION OF CARDIOVASCULAR DISEASES – STATE OF THE ART
Augustin  Scalbert, Laboratoire des Maladies Métaboliques et Micronutriments INRA Centre de Recherche de Clermont-Ferrand/Theix, Saint-Genes-Champanelle, France

15,50-16,15
3. PHYSIOLOGICALLY FUNCTIONAL COMPONENTS FROM MILK AND DAIRY PRODUCTS
Lech Ozimek,  Department of Agricultural, Food & Nutritional Science University of Alberta, Edmonton, Alberta, Canada

16,15-16,30
4. HYPERHOMOCYSTEINEMIA: A “ NEW “ RISK FACTOR IN ATHEROSCLEROSIS
Adolfo B.Bellosillo, Section of Cardiology, Department Internal Medicine, Makati Medical Center, Makati City, Phillipines
 

7,45-8,05
1. TRANS-VALVULAR IMPEDANCE IN THE HEMODYNAMIC REGULATION OF CARDIAC PACING
Franco Di Gregorio, Alberto Barbetta, Raul Chirife *, MEDICO Clinical Research, Rubano (Padova), Italy, * Cardiology Dept., H. Fernandez, Buenos Aires, Argentina

8,05-8,30
2. CAN WE PREVENT ATRIAL FIBRILATION BY ATRIAL PACING ?
Thomas  Buckingham, Slovak Cardiovascular Institute Bratislava,  Slovakia

8,30-8,45
3. EFFECTS OF SILDENAFIL ON CARDIAC REPOLARISATION.
Chern-En Chiang, Division of Cardiology, Taipei Veterans General Hospital, Taipei,  Taiwan

8,45-9,00
4. LONG-TERM FOLLOW-UP VDD VERSUS DDD PACING
 Juraj Bodnár, J. Pella, B. Stančák, P. Čižmárik, P. Kalist, J. Vajó, M. Chyla, R. Šimon, O. Brandebur, I. Stebnický, M. Madar, 3^rd Internal Clinic Faculty Hospital L. Pasteur  Kosice, Slovakia

9,00-9,15
4. LONG TERM HEMODYNAMIC AND QUALITY OF LIFE OUTCOMES OF ATRIOVENTRICULAR JUNCTIONAL  ABLATION IN PATIENTS  WITH CHRONIC AND PAROXYSMAL ATRIAL FIBRILLATION
Branislav Stancak, S. Mišíková, E. Komanová, J. Bodnár, J. Pella, 3^rd Internal Clinic Faculty Hospital L. Pasteur  Kosice, Slovakia

9,15-9,30
5. THE TRANSSEPTAL APPROACH FOR RADIOFREQUENCY CATHETER ABLATION OF CARDIAC ARRHYTHMIAS
Lubos Urban, Peter Margitfalvi, Viliam Fridrich, Peter Lukac, Tibor Malacky, Robert Hatala, Slovak Cardiovascular Institute Bratislava, Slovakia

9,30-9,45
6. SEPTAL ATRIAL PACING TO PREVENT RECURRENT ATRIAL FIBRILLATION (SAPRAF): STUDY DESIGN AND PRELIMINARY RESULTS
Thomas A.  Buckingham, Goran Milasinovic, Jure Mirat, Peter Margitfalvi, Stefan Loeffler, Lubos Urban, Peter Lukac, Tibor Malacky, Robert Hatala, Slovak Cardiovascular Institute Bratislava,  Slovakia, Institute for Cardiovascular Disease, Belgrade, Federal Republic of Yugoslavia, Dubrava University Hospital, Zagreb, Croatia
 
 

07,45–9,45  Hall B CHD AND HYPERTENSION - IDENTIFICATION AND THERAPY OF  HIGH RISK PATIENTS Chairpersons: R.B. Singh, A. Kumar

7,45-8,10
1. BRAIN-HEART CONNECTION AND THE RISK OF HEART ATTACK
Ram B.Singh, Heart Research Laboratory, Moradabad  [UP], India

8,10-8,25
2. OBESITY: A MAJOR PREDISPOSING FACTOR OF CARDIOVASCULAR RISK
G.Neil Thomas, Brian Tomlinson, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong  SAR, China

8,25-8,45
3. VASCULAR DISEASE IN DIABETES MELLITUS IN DEVELOPING COUNTRIES.
Shanti S Rastogi, Ram B. Singh, Diabetes Research Centre, New Delhi, India

8,40-9,00
4. NEW RISK FACTORS FOR CHD - A WORLDWIDE OVERVIEW
Adarsh Kumar, Govt.Medical College/ G.N.D. Hospital, Amritsar, India

9,00-9,15
5.  LOW BIRTH WEIGHT AND HYPERCHOLESTEROLEMIA IN CHILDHOOD.
Peter Szitányi,  Jaroslav Hubáček, Helena Pistulková, Ján Janda, Rudolf Poledne, 1^st Dptm of Paediatrics Charles University Hospital Motol and Institute for Clinical and Experimental Medicine, Prague, Czech Republic

9,15-9,30
6. OUR EXPERIENCE WITH AN INVASIVE APPROACH TO THE MANAGEMENT OF UNSTABLE ANGINA
Martin Studenčan , J. Pavlíková, A. Čverčková, D. Ondušová, E. Prexta, T. Jesenský, Cardiology Center, Kosice, Slovakia

9,30-9,45
7. IMPLEMENTATION OF ARTERIAL HYPERTENSION GUIDELINES IN PRIMARY HEALTH CARE. PILOT STUDY.
Ivan  Majercak, Lýdia Pundová, Martin Rusnák*,  2^nd Internal Clinic Faculty of Medicine, Safarik University, Kosice, Slovakia, * Res. Inst. of Clinical Experimental Medicine, Bratislava, Slovakia

10,15-10,45
1. CLINICAL SIGNIFICANCE OF MYOCARDIAL VIABILITY
C.A.Visser, University Hospital Amsterdam Vrije Universiteit Department of Cardiology, Amsterdam, The Netherlands

10,45-11,15
2. SERIAL EVALUATION OF PERFUSION DEFECTS IN PATIENTS WITH FIRST ACUTE MYOCARDIAL INFARCTION REFERRED FOR PRIMARY PTCA USING INTRAVENOUS MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY
Otto Kamp, W. Lepper, J. Vanoverschelde, B.C. Aeschbacher, D. Rovai, P. Assayag, P. Voci, Y. Kloster, A. Distante, C.A. Visser, University Hospital Amsterdam Vrije Universiteit Department of Cardiology, Amsterdam, The Netherlands

11,15-11,30
3. MITRAL STENOSIS EVALUATED BY THREE-DIMENSIONAL ECHOCARDIOGRAPHY
Gabriel  Valocik, O. Kamp*, H. Mannaerts*, L.You*, C.A. Visser*,    2^nd Department of Internal Medicine, Safarik University, Košice, Slovakia, * Department of Cardiology, Free University Hospital, Amsterdam, The Netherlands

11,30-11,45
4.  USEFULNESS AND CLINICAL SIGNIFICANCE OF SPONTANEOUS BAROREFLEX SENSITIVITY IN PATIENTS AFTER MYOCARDIAL INFARCTION
Jozef Gonsorcik, P. Olexa, A. Farkaš, 4^th Dept. of Internal Medicine University Hosp. L.Pasteur, Kosice, Slovakia
 
 

10,15–11,50 Hall B OTHER CARDIOVASCULAR DISEASES Chairpersons: Sergio Dalla Volta, J. Fabián

10,15-10,35
1. NECROSIS INFORMATION AND ENDOTHELIAL DYSFUNCTION  IN CHRONIC HEART FAILURE
Sergio Dalla Volta, Universita degli Studi di Padova, Dipartimento di Medicina Clinica e Experimentale, Clinica Cardiologica, Padova, Italy

10,35-10,55
2. CARDIOVASCULAR MORBIDITY AFTER HEART TRANSPLANTATION
J. Fabián, E. Goncalvesová, I. Štefanková, Slovak Institute of Cardiovascular Diseases, Bratislava, Slovakia

10,55-11,10
3. ECG in primary pulmonary hypertension.
Murín J., Kiňová S., Bulas J., Jaber J. : I^st Departement of Internal Medicine, Univ. Hosp. Bratislava

11,10-11,25
4. PLASMA NOREPINEPHRINE, HYPERTENSION AND MOXONIDINE
Jozef Pella, P. Kalist, L. Fedakova, 3^rd Internal Clinic LF UPJS, Kosice, Slovakia

11,25-11,40
5. MECHANICAL PROPERTIES OF LARGE ARTERIES: RESULTS OF A POPULATION-BASED STUDY
Jan Filipovsky, Vlasta Šťastná, Milena Tichá, Renata Cífková*,II. Internal Clinic LF UK and FN, Pilsen, Czech republic, * Department of Preventive Cardiology, IKEM, Prague, Czech republic

11,40-11,50
6. SERUM LIPIDS, APOLIPOPROTEINS A-1, B AND ANGIOGRAPHICALLY DEFINED CORONARY ARTERY DISEASE
Stanislav Juhás, M. Kováčová, M. Studenčan, D. Pella*, Heart Center Dept. Cardiology, University Hospital, Kosice, Slovakia, 2 ^nd Internal Clinic, University Hospital, Kosice, Slovakia

12,05-12,35
1. PREHABILITATION: COST-EFFECTIVE CHRONOBIOLOGICAL PREVENTIVE CARE OF NEW VASCULAR DISORDERS
Franz  Halberg, Germaine Cornelissen, R.B. Singh*, Kuniaki Otsuka**, Othild Schwartzkopff, Chronobiology Center, University of Minnesota, Minneapolis, Minnesota, USA, * Heart Research Laboratory, Civil Lines, Moradabad, India,  ** Tokyo Women´s Medical University, Daini Hospital, Tokyo, Japan

12,35-13,00
2. ULTRA-LOW FREQUENCY GEOMAGNETIC PULSATIONS AND CARDIOVASCULAR BIOLOGICAL SYSTEMS IN HUMANS
Kuniaki Otsuka ¹ ,R.B. Singh²,A. Weydahl ³,Y.  Ichimaru ⁴, B. Holmeslet ⁵, T.L. Hansen ⁵, G. Mitutake ¹,   S. Murakami ¹, Y. Kubo ¹ , S.Ohkawa ¹ ,S.Yano ⁶ , M.J.Engebretson ⁷ ,G. Cornelissen ⁸ ,  O. Schawrtzkopff ⁸ , F. Halberg ^8
1 Tokyo Women's Medical University, Tokyo, Japan, ² Medical Hospital and Research Centre, Moradabad, India,
³ Division of Arctic Chronobiology, Finnmark College University, Alta, Norway, ⁴ Department of Clinical Nutrition, Tokyo Kasei University, Tokyo, Japan,  ⁵ Auroral Observatory, University of Tromso, Norway, ⁶ Hokkaido Institute of Public Health, Japan,  ⁷ Ausburg College, Minneapolis,  ⁸ Chronobiology Laboratories, University of Minnesota, Minneapolis

13,00-13,25
3. CIRCADIAN VARIATION : ITS CLINICAL AND CARDIAC REHABILITATION IMPLICATIONS
Adolfo B.Bellosillo, Section of Cardiology, Department Internal Medicine, Makati Medical Center, Makati City, Phillipines
 
 

12,05–13,25  Hall B GENETICS IN CARDIOLOGY Chairpersons: Chern C. Chiang, I.Tkáč

12,05-12,35
1. THE LONG QT SYNDROMES
Chern-En Chiang , National Yang-Ming University Taipei, Taiwan

12,35-12,55
2. GENETICS OF HYPERCHOLESTEROLEMIA. LESSONS FROM FH AND FDB.
Richard  Ceska, A. Horinek, M. Vrablik, Center of Preventive Cardiology  III^rd Internal Clinic 1.School of Medicine Charles University, Prague, Czech Republic

12,55-13,10
3. INTERACTION BETWEEN ANGIOTENSIN-CONVERTING ENZYME GENOTYPE AND GLYCEMIC CONTROL INFLUENCES LIPOPROTEIN LEVELS IN TYPE 2 DIABETES
Ivan Tkáč, M. Kožarová, J. Šalagovič, H. Rosolová, A. Molčanyiová, M. Chleboradová, O. Mayer Jr. I. Skalina,
Department of Internal Medicine IV, Institute of Medical Biology, and Department of Clinical Biochemistry, Faculty of Medicine Safarik university,  Košice, Slovakia, and Department of Internal Medicine II. , Faculty of Medicine in Plzen, Charles University, Praha, Czech Republic

13,10-13,25
4. THE MICROANGIOPATHIC AND MACROANGIOPATHIC COMPLICATIONS IN BOTH TYPES OF DIABETES MELLITUS AND SIGNIFICANCE OF ASSESSMENT  OF ACE GENE POLYMORPHISM
Ivana Rosochová, A. Šufliarska*, Ľ. Podracká, L. Kovács*, Department of Internal Medicine II University Hospital Košice, Slovakia, Children´s University Hospital,  *Laboratory of Molecular Diagnosis, Bratislava, Slovakia
 
 

13,25 - 13,40   Hall A CLOSING REMARKS  Chairpersons: R. B. Singh, R. Hatala, D. Pella

 

1) IS THE MYOCARDIAL CONTRACTILITY INCREASED BEFORE VASOVAGAL SYNCOPE?
Peter  Mitro, E. Hijová*, Rafael Rybár, Gabriel Valočik, Daniel Pella, Dept. of Internal Medicine II, Medical Faculty, Kosice, Slovakia, * Dept. of Experimental Medicine, Medical Faculty, Kosice, Slovakia

2) CLINICAL PRESENTATION OF CORONARY HEART DISEASE IN YOUNG GREEK PATIENTS
Damianos P. Eleftheriadis, Eleni A. Fourla, Kiki Pistevou – Gombaki, Panajiotis Vrizidis, Vassilis Kouloulias, Christos A. Fourlas, Nikos Eleftheriadis,  Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida,
Thessaloniki,  Greece

3) PROGNOSTIC SIGNIFICANCE OF PAROXYSMAL VENTRICULAR TACHYCARDIA IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION
Mislav Klobucic, Mario Ivanusa, Vlasta Soukup Podravec, Department of Internal Medicine, General Hospital, Bjelovar, Croatia

4) CAN CLINICAL EFFECTS OF PERMANENT ATRIAL PACING  BE ANTICIPATED ?
Andrzej  Kutarski, Krzysztof Oleszczak, Piotr Rucinski, Teresa Widomska – Czekajska, Department of Cardiology University Medical School of Lublin, Lublin, Poland

5) COMPARATIVE EVALUATION OF STATINS TOXICITY BY THE USE OF ANIMAL MODELS
Juan C. Díaz-Zagoya,  Miguel A.  Piedras-Huerta,  Jorge L. Blé Castillo,  Juan C. Asenjo-Barrón, Rodrigo Miranda-Zamora, Marco A. Juárez-Oropeza, Facultad de Medicina, UNAM, Mexico City, Mexico
 
6) TUMOR NECROSIS FACTOR ALPHA  AND TRANSFORMING GROWTH FACTOR BETA IN PATIENTS WITH HYPERTENSION.
Dana  Škultétyová* ,  S. Filipová*, L. Desser**, B.Liška* I.Riečanský*, Slovak Institute of Cardiovascular Diseases, Dept. Cardiology, Bratislava, Slovakia,** Institute of Experimental Oncology, Vienna, Austria
 
7) HOMOCYSTEINE SERUM CONCENTRATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Halina Klepacka, Martin Skorski, *, Beata Wojtysiak, Department of Cardiology Stefan Cardinal Wyszynski Regional Hospital, Lublin, Poland,  * Interfaculty Department and Division  of Public Health, Medical Academy in Lublin, Poland

8) TRACE ELEMENTS IN DILATED CARDIOMYOPATHY
G.Subramanyam,  S. A. A. Latheef, S.V.Institute Of Medical Sciences, Tirupati, India

9) CORONARY ARTERY FISTULA TO THE CORONARY SINUS TREE
A. Tomaszewski, W. Brzozowski,  T. Widomska – Czekajska, Medical University School, Lublin, Poland

10) METHOD FOR HEART FAILURE DIAGNOSTICS BASED ON THE QUANTITATIVE ASSESSMENT OF THE FRANK-STARLING GRAPH
Igor Polonetsky,   Ludmila Lakhanko, Leonid Polonetsky, Research-Practical Centre "Cardiology", Minsk, Belarus
 
11) LEFT VENTRICULAR HYPERTROPHY AND GEOMETRY  IN ESSENTIAL FORM OF SYSTEMIC HYPERTENSION IN CHILDREN
Alexander Jurko, Alexander Jurko Jr., Zora Farska, Anna Sparcova, Pediatric Department of JLF UK, Martin, Slovakia

12) DECREASED COENZYME Q10 LEVEL IN PATIENTS WITH HEART FAILURE DEPENDENT ON NYHA FUNCTIONAL CLASSIFICATION
Jarmila Kucharska, A. Gvozdjáková, K. Dulková*, Z. Sumbalová, V. Bada*, Faculty of Medicine, Pharmacobioch. Lab., Bratislava, Slovakia, 3 rd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia

13) FACTORS DETERMINING THE APPEARANCE OF PAROXYSMAL ATRIAL ARRHYTHMIA
Piotr Ruciński, Marek Konieczny*, Andrzej Kutarski,  Teresa Widomska-Czekajska   Department of Cardiology University Medical School of Lublin, Lublin, Poland,  *Department of Cardiology of Pulawy Hospital, Poland
 
14) INTERATRIAL SEPTUM PACING OR DUAL  SITE RIGHT ATRIAL PACING -ASSESSMENT OF P WAVE SIGNAL-AVERAGED TIME DOMAIN PARAMETERS
Andrzej  Kutarski, D. Szczesniak, T. Widomska-Czekajska, Department of Cardiology University Medical School of Lublin, Lublin, Poland

15) NITRIC OXIDE PRODUCTION AND ARACHIDONIC ACID METABOLISM IN PLATELET MEMBRANES
Peteris Tretjakovs, U. Kalnins, I. dabina, I. Dinne, A. Erglis, G. Latkovskis, A. Jurka, V. Pirags,  Centre of Cardiology and Centre of Endocrinology, P. Stradins Clinical University Hospital, Riga, Latvia
 
16) CORRELATION BETWEEN ABDOMINAL OBESITY (AO) WITH OTHER CARDIOVASCULAR RISK FACTORS ( CRF ) IN PATIENTS OVER 65 YEARS WITH ISCHAEMIC STROKE
Apostolos Hatzitolios,  CH. G. Savopoulos, N.Ch. Markoglou, A.G. Ziakas, P. Paschalides, Ch. P. Delivoria, D.T. Tsambazis, 1st Medical Propedeutic Department – AHEPA Hospital, Aristotelian University Thessaloniki, Greece

17) CORRELATION BETWEEN OVERWEIGHT ( OW ), SEX AND AGE WITH ISCHEMIC STROKE IN ELDERLY PATIENTS
Apostolos I. Hatzitolios, N. Ch. Markoglou, Ch. G. Savopoulos, A.G. Ziakas, A.D. Kounanis, M. Kosmidou, N. Eleftheriades, D. Vakalis, 1st Medical Propedeutic Department – AHEPA Hospital, Aristotelian University Thessaloniki, Greece

18) EARLY VISUALIZATION OF ISCHEMIC CEREBROVASCULAR ATTACKS ( I-CVA/S) ON CT IN PATIENTS OVER 65 IS RELATED TO CERTAIN CARDIOVASCULAR RISK FACTORS
Apostolos I. Hatzitolios, Ch.G.  Savopoulos, F.S. ILiades, A.G. Ziakas,A.D. Kounanis, F. Girtovitis, A. Dimitriades,  1st Medical Propedeutic Department – AHEPA Hospital, Aristotelian University Thessaloniki, Greece

19) TIME OF ISCHEMIC CEREBRAL INFARCTS (I-CI) IMAGING ON CT IN PATIENTS OVER 65 YRS IN REALTION WITH AGE, SEX AND CONCOMITANT CARDIOVASCULAR RISK FACTORS ( CVRF)
Apostolos I. Hatzitolios,  F.S. ILiades, Ch.G.  Savopoulos, A.G. Ziakas, K.Mikoudi, Ch. Magripli, M. Alevizos, 1st Medical Propedeutic Department – AHEPA Hospital, Aristotelian University Thessaloniki, Greece

20) IMMUNOLOGICAL MARKERS OF DISEASE  PROGRESSION IN PATIENTS WITH CAROTID ATHEROSCLEROSIS
E. Profumo, A. Siracusano, E. Ortona, P. Margutti, R. Capoano*, B. Salvati*, Rachele Rigano, Immunology Laboratory, Instituto Superiore di Sanita, Rome, Italy,  * Instituto di III Clinica Chirurgica, Universita´ „ La Sapienza „ , Rome, Italy

21) HUMORAL IMMUNE RESPONSE TO A 12KDA ANTIGEN IN PATIENTS WITH CAROTID ATHEROSCLEROSIS
Federica Delunardo, Paola Margutti,  Rachele Rigano, Elisabetta Profumo, Alessandra Siracusano, Bruno Salvati*, Alessandro Costanzo *,  Alessandro Carra , Raffaele Capoano *, Elena Ortona,    Immunology laboratory, Instituto Superiore di Sanita, Rome, Italy,  * III Clinica Chirurgica, Universita  „ La Sapienza“, Rome, Italy

22) NON-LINEARLY ALTERED VASCULAR VARIABILITY CONSTITUTES RISK GREATER THAN HYPERTENSION
Othild Schwartzkopff,  Germaine Cornélissen, Earl E. Bakken, R.B. Singh & Franz Halberg
Halberg Chronobiology Center, University of Minnesota, Minneapolis, MN, USA

23) HOMOCYSTEINE SERUM CONCENTRATION AS A PROGNOSTIC FACTOR AT PATIENTS WITH Q-WAVE MYOCARDIAL INFARCTION
Waldemar Ruminski,  Marcin Skorski*, Halina Klepacka, Beata Wojtysiak,Przemyslaw Firych, Janusz Solski, Department of Cardiology Stefan Cardinal Wyszynski Hospital, Lublin, Poland,  * Interfaculty Department and Division of Public Health, Medical Academy,  Lublin, Poland

24) EFFECT OF ACUTE FAT LOAD ON POSTPRANDIAL SERUM TRIGLYCERIDE AND HDL-CHOLESTEROL LEVELS
J. Franeková ²  Ivan Tkáč, A. Gábrišová ³ , Š. Farský ⁴ , J. Slávik ⁵ , Department of Internal Medicine IV, Faculty of Medicine, University of Kosice, Kosice, Slovakia, ² Department of Clinical Biochemistry, Zilina Hospital, ³ Diabetes Outpatient Clinic, Trencin,  ⁴ Dom srdca, Cardiologic Outpatient Clinic, Martin,  ⁵ Department of Cybernetics, University of Zilina, Slovakia

25) THE STATUS OF BLOOD PRESSURE CONTROL IN A HYPERTENSIVE GROUP OF POPULATION
Sabah Mikhael Yacoub, Department of Medicine College of Medicine, University of Baghdad, Baghdad, Iraque

26) BIOENERGY OF CARDIAC MITOCHONDRIA OF DIABETIC RATS AFTER LOSARTAN ADMINISTRATION
Olga Ulicna, V. Bada, M. Cizova, J. Carsky*, L. Cibulova**, Pharmacobiochem. lab. the 3rd Dept. of Internal Medicine Comenius University, Bratislava, Slovakia, *Institute of Chemistry and Biochemistry of Medical School Comenius University, Bratislava, Slovakia , ** Department of Clinical Pharmacology, Institute of Preventive a Clinical Medicine, Bratislava, Kosice

27) THE ROLE OF THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION IN ELDERLY PATIENTS
Damianos  P. Eleftheriadis,  Eleni A. Fourla, Kiki Pistevou – Gompaki, Nikos P. Eleftheriadis, Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida, Thessaloniki, Greece

28) ABORTION OF MYOCARDIAL INFARCTION- WELL KNOWN PHENOMENON ?
Waldemar Ruminski, Marcin Skorski*, Andrzej Witkowski, Gerard Grossmann, Halina Klepacka, Przemyslaw Firych, Department of Cardiology Stefan Cardinal Wyszynski Regional Hospital, Lublin, Poland,  * Interfaculty Department and Division of Public Health, Medical Academy in Lublin, Poland

29) LIPID LOWERING DRUGS – MONOTHERAPY OR COMBINATION ? COMPARISON OF SAFETY AND EFFICACY.
Daniel Pella, Rafael Rybár, Peter, Mitro, Gabriel Valočik, Dušan Trejbal, 2nd Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia

30) ABORTION OF MYOCARDIAL INFARCTION – QUEST OF THE FACTORS CAUSING A PHENOMENON.
Marcin Skorski, Andrzej Witkowski*, Waldemar Ruminski*, Gerard Grossmann*, Przemyslaw Firych, Department of Cardiology Stefan Cardinal Wyszynski Regional Hospital, Lublin, Poland,  * Interfaculty Department and Division of Public Health, Medical Academy, Lublin, Poland

31) ACUTE CORONARY SYNDROMES WITHOUT Q WAVE AND DIABETES MELLITUS
Ekaterina Amosova, National Medical University of Ukraine named after A.A. Bogomolets, Kiev, Ukraine

32)  ISOLATED RIGHT HEART FAILURE AS FIRST CLINICAL MANIFESTATION OF HYPERTHYROIDISM IN A YOUNG MALE PATIENT
Damianos Eleftheriadis,  Eleni A. Fourla, Panajiotis Vrizidis, Kiki Pistevou – Gompaki, Vassilis Kouloulias, Christos A. Fourlas, Nikos P. Eleftheriadis,  Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida, Thessaloniki, Greece

33) USE OF CARDIOVASCULAR MEDICATIONS AT DISCHARGE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Mario Ivanusa, Vlasta Soukup Podravec, Mislav Klobucic, Department of Internal Medicine, General Hospital, Bjelovar, Croatia
 
34) RIGHT ATRIAL PACING VERSUS CORONARY SINUS PACING - P WAVE SIGNAL AVERAGED DOMAIN PARAMETERS
D. Szcesniak, A.Kutarski, A. Glowniak, Department of Cardiology University Medical School of Lublin, Lublin, Poland
 
35)  HOW SIGNAL –AVERAGED ECG CHANGES DURING DIFFERENT MODE OF VENTRICULAR PACING IN PATIENTS WITH CONGESTIVE HEART FAILURE
D.  Szczesniak, Andrzej  Kutarski,  A. Glowniak, T. Widomska – Czekajska, Department of Cardiology University Medical School of Lublin, Lublin, Poland

36) ATRIAL RESYNCHRONIZATION IN PATIENTS AFTER HEART TRANSPLANTATION
Andrzej  Kutarski*, M. Zakliczynski **., K. Oleszczak*, J. Kusnierz***, B. Lech***, J. Wojarski**, M. Zembala**, T. Widomska-Czekajska*, Z. Religa***    *Department of Cardiology University Medical School of Lublin, Lublin, Poland, ** Dept. of Transplant. Silesian Med. Acad. Zabrze, Poland, ***Dept. of Cardiology Central Clin. Hospital for the Ministry of Internal Affairs and Administration, Poland

37) TRANSESOPHAGEAL CARDIOVERSION USING MONO- AND BIPHASIC SHOCK IN PATIENTS AFTER CABG
Andrzej  Kutarski, Krzysztof Oleszczak, Elzbieta Krawczyk*, Janusz Stazka*, Department of Cardiology University Medical School of Lublin, Lublin, Poland, Dept. of Cardiosurgery., University Medical School of Lublin, Poland

38) ATRIAL PACING OF TRANSPLANTED HEART
Andrzej  Kutarski, M. Zakliczynski*, K. Oleszczak, J. Kusnierz**, B. Lech**, B. Lakomski, J. Wojarski*, M. Zembala*, T. Widomska- Czekajska, Z. Religa*,  Department of Cardiology University Medical School of Lublin, Lublin, Poland, Dept. of Transplant. Silesian Med. Acad., Zabrze, Poland, ** Dept. of Cardiology Central Clin. Hospital for the Ministry of Internal Affairs, Poland

39) NEW AREAS OF APPLICATION FOR SINGLE LEAD DUAL CHAMBER PACING
Juraj Bodnár, J. Pella, B. Stančák, P. Čižmárik, P. Kalist, J. Vajó, 3 rd Internal Clinic Faculty Hospital L. Pasteur, Kosice, Slovakia

40) APOLIPOPROTEINS B, C-II, C-III, SOME LIPIDS AND ASCORBIC ACID IN OBESE MEN OF MIDDLE AGE
Judita Koprovicova,  D. Petrášová, M. Kuchta, Institute of Experimental Medicine,  Medical Faculty UPJS, Kosice, Slovakia

41) FACTOR V LEIDEN AS A RISK FACTOR FOR ACUTE MYOCARDIAL INFARCTION IN YOUNG PATIENTS
M. Quitt, A. Cassel, R. Kaufman, E. Aghai, H. Shapira, N. Lindenfeld, J. Senderowicz, L. Slezak, Carmel Medical Center,Department of Diabetes and Hypertension, Linn Medical Center, Haifa, Israel

42) THE APOLIPOPROTEIN B-100 ITS ROLE IN DETERIORATION OF THE HEALTH AND FACTORS RESULTING ON ITS PRODUCTION , SECERNATION AND LIGATION
Jozef Kollar, J. Koprovičová, V. Rozdobuďková, Institute of Experimental Medicine, Medical Faculty UPJS, Kosice, Slovakia

43) OBESITY INDUCED HEMODYNAMIC AND LIPID CHANGES
Emilia Hijova, Darina Petrasova, Institute of Experimental Medicine, Medical Faculty UPJS, Kosice, Slovakia

44) IMMUNOGLOBULIN E CHANGES AFTER MYOCARDIAL INFARCTION
Darina Petrasova, Institute of Experimental Medicine, Medical Faculty UPJS, Kosice, Slovakia

45)  THE NEW APPROACH TO DIAGNOSTICS OF AN INITIAL STAGE OF HEART FAILURE
Igor Polonetsky, Ludmila Lakhanko, Leonid Polonetsky, Research-Practical Centre "Cardiology", Minsk, Belarus

46) DEPRESSIVE DISORDERS IN PATIENTS AFTER MYOCARDIAL INFARCTION -  ONE YEAR FOLOW UP.
Peter Mosčovič, E. Palová*, P. Šefara, D. Balcová, D. Breznoščáková* , J. Sokoliová*, E. Szokeová, 1st Clinic Faculty of Medicine,  Safarik University, Kosice, Slovakia,  * Psychiatry Dept. Faculty of Medicine, Safarik University, Kosice

47) ANTIPHOSPHOLIPID SYNDROME IN BEHIND OF SERIOUS CARDIOVASCULAR COMPLICATIONS IN PATIENTS IN CARDIOLOGY CENTRE.
Jana Pavlíková, M. Studenčan, M. Hulíková*,  Cardiology Centre, Kosice, Slovakia,
Regional centre of Haemostasis and Thrombosis, Kosice, Slovakia

48) HELICOBACTER PYLORI SEROPREVALENCE IN ACUTE MYOCARDIAL INFARCTION.
Ján Pobeha, Gabriel Valočik, Dušan Trejbal, 2nd Department of Internal Medicine, Safarik University, Kosice, Slovakia

49) THE NECESSITY OF GASTROPROTECTION DURING THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION
Damianos P. Eleftheriadis,  Eleni A. Fourla, Kiki P. Pistevou – Gompaki, Dimitris Mpetsis, Nikos P. Eleftheriadis,  Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida,Thessaloniki, Greece

50) EVALUATION OF ACUTE CARDIOTOXICITY AFTER RADIOTHERAPY FOR LUNG AND LEFT BREAST CANCER WITH ECHOCARDIOGRAPHY
Damianos Eleftheriadis,  Kiki Pistevou – Gompaki, Georgios Savopoulos, Nikos Eleftheriadis, Georgios Louridas, Ioanis Sofroniadis,  Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida, Thessaloniki, Greece

51) ACUTE MYOCARDIAL INFARCTION IN A YOUNG PATIENT WITH HYPERTHYROIDISM AND SEVERE HYPOCALCEMIA  LONG AFTER SUBTOTAL THYROIDECTOMY
Damianos Eleftheriadis, Fourla Eleni, Vrizidis Panajiotis, Nikos Eleftheriadis,  Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida, Thessaloniki, Greece

52) CORRELATION OF SYSTOLIC AND DIASTOLIC HYPERTENSION WITH CARDIOVASCULAR RISK FACTORS
Guntis Bahs, Latvian Medical Academy, Riga, Latvia

53) HYPERHOMOCYSTEINEMIA  AS  INDEPENDENT CARDIOVASCULAR RISK FACTOR IN PATIENTS WITH ISCHEMIC STROKE
Apostolos  I. Hatzitolios, Ch. G. Savopoulos, M.A. Chatzidimitriou, E. Tsirogianni, F. I. Girtovitis, A. G. Ziakas, I. Pidonia, A. Papadopoulos,  1st Medical Propedeutic Department – AHEPA Hospital, Aristotelian University, Thessaloniki, Greece

54) SECONDARY PREVENTION OF ATHEROSCLEROSIS BY COMBINED TREATMENT WITH FLUVASTATIN AND SULODEXIDE
Daniel Pella, Rafael Rybár, Dušan Trejbal, Darina Petrášová*, Gabriel Valočik, Peter Mitro, 2nd  Internal Clinic Faculty of Medicine P.J.Safarik University, Kosice, Slovakia, * Institute of Experimental Medicine P.J. Safarik University, Kosice, Slovakia

55) THE EFFECTS OF ATORVASTATIN AND CERIVASTATIN ON RESISTANCE OF LDL TO OXIDATION AND LIPOPROTEIN SUBFRACTIONS IN HYPERLIPIDAEMIA PATIENTS
Yu. Nikitin, Yu. Ragino, N. Filatova, Yu. Parlyuk, F. Tuzikov, N. Tuzikova, Institute of Internal Medicine  Novosibirsk , Russia

56) THE EFFECTS OF CIPROFIBRATE TREATMENT ON SOME BLOOD LIPID PARAMETERS IN HYPERCHOLESTEROLEMIA PATIENTS
G. Simonova, N. Filatova, F. Tuzikov, N. Tuzikova, Yu. Ragino, Institute of Internal Medicine, Novosibirsk, Russia

57) COMPARISON OF TWO THROMBOLYTIC AGENTS (RETEPLASE VS ALTEPLASE) IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION
Damianos Eleftheriadis, Fourla Eleni, Pistevou-Gompaki Kiki, Kouloulias Vassilis, Vrzidis Panajiotis, Fourlas Christos Eleftheriadis Nikolaos, Cardiology Department of 'Mpodosakio' Hospital of Ptolemaida, Thessaloniki, Greece

58) ANTIOXIDANTS, DIABETES MELLITUS AND DISEASES OF THE  CARDIOVASCULAR SYSTEM
Lýdia Pundová,  D. Petrášová*, E. Hijová*, V. Lacková**, B. Zábranská, 2 nd Department of  Internal Medicine, Safarik University ,Kosice, Slovakia, * Institute of Experimental Medicine, Kosice, Slovakia, ** 1 st Department of Internal Medicine, Safarik University, Kosice,  Slovakia

59) RELATIONSHIP BETWEEN PLASMA ALDOSTERONE AND LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
B. Zábranská, I. Lazúrová, E. Fraenkel, G. Valočik, D. Trejbal, 2nd  Department of Internal Medicine, Medical Faculty,  Kosice, Slovakia

60) LEFT MAIN CORONARY ARTERY OCCLUSION THERAPY  / CASE REPORT /
Eduard Curilla, Viliam Fischer*, Viliam Fridrich**, University Hospital, Kosice, Slovakia, * Clinic of Cardiosurgery, ** Clinic of Cardiology, Slovak Institute of cardiovascular Disease, Bratislava, Slovakia

61) ASSESSMENT OF THE LEFT ATRIAL APPENDAGE MECHANICAL FUNCTION BY THREE-DIMENSIONAL ECHOCARDIOGRAPHY
Gabriel  Valocik, O. Kamp*, M. Mihciokur*, H. Mannaerts*, L. You*, S. Ripa*, C.A.Visser*, 2nd Department of Internal Medicine ,Safarik University, Kosice, Slovakia, *Department of Cardiology, Free University Hospital, Amsterdam, The Netherlands

62) DEPRESSION AFTER SERIOUS VASCULAR EVENTS
Eva Havlíková, Eleonóra Klímová, Vladimír Pavlík, Luboš Skička,Neurological Clinic Faculty of Medicine, Kosice, Slovakia

63) HEART RATE VARIABILITY IN VASOVAGAL SYNCOPE.
Peter  Mitro, Dept. of Internal Medicine II, Medical Faculty, Kosice, Slovakia

64) RED CELL ANTIOXIDANT ENZYMES, PLASMA ANTIOXIDANT CAPACITY AND LIPID METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Anna Šipulová ,  Eva Lovásová, Gabriela Mojžišová, Viera Doničová, Gabriela Ivančová, Peter Dombrovský, Milan Kuchta, Oliver Rácz,UEM, Medical Faculty, Safarik University, Kosice, Slovakia

65) MORPHOLOGICAL AND FUNCTIONAL CHANGES OF RAT MYOCARDIAL MICROCIRCULATION SYSTEM IN IMMOBILIZATION STRESS
Anna Semerjyan, Sos H. Sisakian,  Nikolay F. Krasnikov, Marina G. Susanian, Yerevan State Medical University,Yerevan, Armenia

66) POTENTIAL OF MESENCHYMAL STEM CELL FOR TISSUE REGENERATION
Ján Rosocha, Vasiľ Čorňák*, Tissue Bank of the Faculty of Medicine and University Hospital, Kosice, Slovakia, * Cardiology Center, Kosice, Slovakia

67) THE INFLUENCE OF HYPERTENSION AND GENDER ON CEREBROVASCULAR DISEASES
Jasna Badzak, Zrinka Ivanusa, Mario Ivanusa*, Mislav Klobucic*
Department of Neurology, *Department of Internal Medicine, General Hospital, Bjelovar,  Croatia

68) URINE MAGNESIUM EXCRETION OF HYPERTENSIVE ADOLESCENT BOYS
Ž. Drižienė¹, D. Stakišaitis², I. Kuliešienė^{2  1}Central Pediatric Policlinics of Vilnius District; ²Centre of Pediatrics, Vilnius University Medical Faculty; Vilnius, Lithuania

69) CHRONOBIOLOGICAL REASONS FOR REVISION OF GUIDELINES FOR BLOOD PRESSURE AND HEART RATE SCREENING
Germaine Cornélissen*, R.B. Singh•, K. Otsuka‡, Y. Watanabe‡, Othild Schwartzkopff*,
Franz Halberg*, *Halberg Chronobiology Center, University of Minnesota, Minneapolis, Minnesota, USA
•Medical Hospital and Research Centre, Centre of Nutrition and Heart Research, Moradabad, India
‡Tokyo Women's Medical University, Tokyo, Japan

70) ELECTROPHYSIOLOGICAL EVALUATION OF AMIODARONE TREATMENT EFFICIENCY: ROLE OF THE MANAGEMENT OF SUSTAINED MONOMORPHIC VENTRICULAR TACHYCARDIA
Jan Sedlak, Adriana Cverckova, Zuzana Machacova, Radovan Molcan, Cardiology Center, Kosice, Slovakia